Portfolio Holdings

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Home > Funds > CF Woodford Equity Income Fund > Portfolio Holdings

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction.

To keep our investors informed, we are committed to providing full disclosure of the CF Woodford Equity Income Fund’s holdings on a monthly basis.

Please find the portfolio holdings as at 31 August 2017 below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Register now to receive Portfolio disclosure alerts by email.

CF Woodford Equity Income Fund As at 31 August 2017
  Name Industry % (weight)
1 AstraZeneca Health Care 8.63
2 Imperial Brands Consumer Goods 6.53
3 Legal & General Financials 5.62
4 Prothena Health Care 3.89
5 Lloyds Financials 3.22
6 Burford Capital Financials 2.94
7 Purplebricks Financials 2.56
8 Benevolent AI (unquoted) Technology 2.27
9 Theravance Biopharma Health Care 2.19
10 NewRiver REIT  Financials 2.07
11 Capita Industrials 2.02
12 Taylor Wimpey  Consumer Goods 2.02
13 Stobart Industrials 2.01
14 Babcock International Industrials 1.96
15 Provident Financial Financials 1.84
16 Lancashire Financials 1.73
17 Next Consumer Services 1.64
18 Alkermes Health Care 1.62
19 BTG Health Care 1.47
20 BCA Marketplace Industrials 1.44
21 Barratt Developments  Consumer Goods 1.43
22 G4S Industrials 1.35
23 Spire Healthcare Health Care 1.29
24 Homeserve Industrials 1.26
25 Oxford Nanopore (unquoted) Health Care 1.18
26 Drax Utilities 1.14
27 Micro Focus Technology 1.11
28 Eddie Stobart Logistics  Industrials 1.08
29 Countryside Properties Consumer Goods 1.06
30 Redde Financials 1.06
31 Malin Financials 1.01
32 Paypoint Industrials 0.97
33 British Land Financials 0.96
34 P2P Global Financials 0.91
35 Forterra Industrials 0.90
36 Touchstone Innovations Financials 0.88
37 IP Group Financials 0.85
38 Idex Technology 0.83
39 AA Industrials 0.78
40 Hostelworld Consumer Services 0.73
41 Horizon Discovery Health Care 0.71
42 Equiniti Industrials 0.70
43 Oakley Capital Financials 0.68
44 Breedon Industrials 0.65
45 Watkin Jones Consumer Goods 0.64
46 Raven Russia (Convertible Pref) Financials 0.63
47 Allied Minds Financials 0.62
48 Phoenix Spree Deutschland Financials 0.61
49 CityFibre Telecommunications 0.59
50 Benchmark Health Care 0.57
51 VPC Specialty Lending Financials 0.57
52 Thin Film Electronics Industrials 0.56
53 Immunocore A (unquoted) Health Care 0.54
54 Mereo Biopharma Health Care 0.54
55 Xeros Industrials 0.53
56 4D Pharma Health Care 0.52
57 Non-Standard Finance Financials 0.52
58 Viamet (unquoted) Health Care 0.51
59 Honeycomb Investment Trust Financials 0.50
60 Atom Bank (unquoted) Financials 0.49
61 Circassia Health Care 0.49
62 Verseon Health Care 0.43
63 Arix Bioscience  Financials 0.36
64 Draper Esprit Financials 0.36
65 Gigaclear (unquoted) Telecommunications 0.35
66 Raven Russia (Convertible Pref 6.5%) Financials 0.35
67 Raven Russia Financials 0.35
68 Evofem D (unquoted) Health Care 0.34
69 London Metric Property Financials 0.33
70 Tissue Regenix Health Care 0.33
71 Crystal Amber Financials 0.32
72 Eurocell Industrials 0.32
73 Oxford Sciences Innovation (unquoted) Financials 0.30
74 Sabina Estates Pref  (unquoted) Financials 0.30
75 Time Out Consumer Services 0.30
76 Sirius Real Estate Financials 0.28
77 Proton Partners International (unquoted) Health Care 0.27
78 Eve Sleep Consumer Goods 0.25
79 Ombu Pref (unquoted) Financials 0.23
80 Spin Transfer Technologies (unquoted) Technology 0.23
81 Cequr (unquoted) Health Care 0.21
82 Mercia Technologies Financials 0.21
83 Abzena Health Care 0.20
84 Mafic (unquoted) Industrials 0.20
85 Softcat Technology 0.20
86 Vernalis Health Care 0.19
87 A J Bell (unquoted) Financials 0.18
88 Strix Industrials 0.18
89 Cell Medica (unquoted) Health Care 0.16
90 Nexeon (unquoted) Industrials 0.16
91 Accelerated Digital Ventures A (unquoted) Financials 0.14
92 AMO Pharma (unquoted) Health Care 0.12
93 Autolus (unquoted) Health Care 0.12
94 Hvivo Health Care 0.12
95 ReNeuron Health Care 0.12
96 Ratesetter (unquoted) Financials 0.12
97 Kymab B Pref  (unquoted) Health Care 0.11
98 RM2 International (Convertible Pref)   Industrials 0.11
99 Industrial Heat (unquoted) Industrials 0.10
100 Origin (unquoted) Health Care 0.10
101 Utilitywise Industrials 0.10
102 Card Factory Consumer Services 0.09
103 Drayson Technologies C (unquoted) Technology 0.09
104 Midatech Pharma Health Care 0.09
105 Cambridge Innovation Capital (unquoted) Financials 0.08
106 Precision Biopsy (unquoted) Health Care 0.08
107 Mission Therapeutics (unquoted) Health Care 0.07
108 Federated Wireless (unquoted) Technology 0.06
109 Industrial Heat A2 Pref (unquoted) Industrials 0.06
110 Immunocore (unquoted) Health Care 0.06
111 ABLS Capital (unquoted) Health Care 0.06
112 Netscientific Health Care 0.06
113 Novabiotics (unquoted) Health Care 0.06
114 Viamet (unquoted) Health Care 0.06
115 Mafic B (unquoted) Industrials 0.05
116 RM2 International Industrials 0.05
117 Sabina Estates (unquoted) Financials 0.05
118 Carrick Therapeutics (unquoted) Health Care 0.04
119 e-Therapeutics Health Care 0.04
120 Itaconix Basic Materials 0.04
121 Kymab C (unquoted) Health Care 0.04
122 Metalysis (unquoted) Industrials 0.04
123 Oxford Pharmascience Health Care 0.04
124 Genomics (unquoted) Health Care 0.03
125 Emba (unquoted) Health Care 0.02
126 Brave Bison Technology 0.02
127 Halosource Reg S Industrials 0.02
128 Northwest Biotherapeutics Health Care 0.02
129 Emba - Series 2 (unquoted) Health Care 0.01
130 Origin (convertible pref) (unquoted) Health Care 0.01
131 Evofem (unquoted) Health Care 0.01
132 Evofem C (unquoted) Health Care 0.01
133 Synairgen Health Care 0.01

What are the risks?

  • The value of the fund and any income from it may go down as well as up, so you may get back less than you invested
  • Past performance cannot be relied upon as a guide to future performance
  • The annual management charge is charged to capital, so the income of the fund may be higher but capital growth may be restricted or capital may be eroded
  • The fund may invest in other transferable securities, money market instruments, warrants, collective investment schemes and deposits
  • The fund may invest in overseas securities and be exposed to currencies other than pound sterling
  • The fund may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

Before investing, you should read the Key Investor Information Document (KIID) for the fund, and the Prospectus which, along with our terms and conditions, can be obtained from the downloads page or from our registered office. If you have a financial adviser, you should seek their advice before investing. Woodford Investment Management Ltd is not authorised to provide investment advice.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address 40 Dukes Place, London EC3A 7NH.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement